ArticleFrontiers in immunology2022

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival.

Ruo-Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.